Geneos Wealth Management’s Walgreens Boots Alliance WBA Stock Holding History

Geneos Wealth Management’s Portfolio WBA Stock Details WBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,178	Closed	-$232K	–	3188
2025 Q2	$232K	Sell	20,178 -22,282	-52%	-$248K	0.01%	941
2025 Q1	$474K	Buy	42,460 +22,237	+110%	+$241K	0.01%	909
2024 Q4	$189K	Sell	20,223 -1,718	-8%	-$16K	0.01%	864
2024 Q3	$197K	Buy	21,941 +5,540	+34%	+$57K	0.01%	775
2024 Q2	$198K	Buy	16,401 +462	+3%	+$7.83K	0.01%	708
2024 Q1	$346K	Buy	15,939 +41	+0.3%	+$911	0.02%	571
2023 Q4	$415K	Sell	15,898 -5,940	-27%	-$133K	0.02%	526
2023 Q3	$486K	Sell	21,838 -648	-3%	-$17.2K	0.03%	474
2023 Q2	$641K	Buy	22,486 +8,661	+63%	+$282K	0.03%	415
2023 Q1	$478K	Sell	13,825 -4,090	-23%	-$145K	0.03%	453
2022 Q4	$669K	Buy	17,915 +8,223	+85%	+$309K	0.04%	359
2022 Q3	$304K	Sell	9,692 -7,113	-42%	-$264K	0.02%	499
2022 Q2	$648K	Buy	16,805 +3,017	+22%	+$130K	0.03%	428
2022 Q1	$617K	Buy	13,788 +1,029	+8%	+$50.6K	0.03%	486
2021 Q4	$665K	Sell	12,759 -3,944	-24%	-$191K	0.03%	497
2021 Q3	$781K	Buy	16,703 +358	+2%	+$17.3K	0.03%	451
2021 Q2	$787K	Sell	16,345 -8,735	-35%	-$470K	0.03%	439
2021 Q1	$1.33M	Buy	25,080 +168	+0.7%	+$8.3K	0.04%	350
2020 Q4	$1.02M	Buy	24,912 +12,451	+100%	+$482K	0.04%	340
2020 Q3	$441K	Sell	12,461 -5,037	-29%	-$197K	0.02%	463
2020 Q2	$720K	Buy	17,498 +228	+1%	+$9.68K	0.04%	343
2020 Q1	$759K	Sell	17,270 -950	-5%	-$48.2K	0.05%	296
2019 Q4	$1.07M	Buy	18,220 +1,904	+12%	+$110K	0.06%	286
2019 Q3	$887K	Sell	16,316 -9,675	-37%	-$518K	0.05%	295
2019 Q2	$1.42M	Sell	25,991 -7,835	-23%	-$417K	0.09%	219
2019 Q1	$2.14M	Buy	33,826 +4,289	+15%	+$293K	0.14%	174
2018 Q4	$2.02M	Buy	29,537 +2,268	+8%	+$176K	0.15%	164
2018 Q3	$1.99M	Buy	27,269 +1,652	+6%	+$112K	0.13%	174
2018 Q2	$1.54M	Sell	25,617 -136	-0.5%	-$8.76K	0.12%	170
2018 Q1	$1.69M	Buy	25,753 +350	+1%	+$25K	0.15%	143
2017 Q4	$1.84M	Buy	25,403 +9,089	+56%	+$640K	0.16%	139
2017 Q3	$1.26M	Sell	16,314 -2,207	-12%	-$177K	0.13%	170
2017 Q2	$1.45M	Buy	18,521 +1,087	+6%	+$89.4K	0.15%	146
2017 Q1	$1.45M	Buy	17,434 +4,886	+39%	+$410K	0.15%	137
2016 Q4	$1.04M	Sell	12,548 -7,809	-38%	-$646K	0.14%	157
2016 Q3	$1.64M	Sell	20,357 -359	-2%	-$29.3K	0.22%	109
2016 Q2	$1.72M	Buy	20,716 +131	+0.6%	+$10.6K	0.25%	96
2016 Q1	$1.78M	Buy	+20,585	New	+$1.64M	0.27%	91

Other funds holding WBA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GCM

Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PayPay Securities Tokyo, Japan $2.89M AUM 12.57% 1-Year Est. Return

Geneos Wealth Management's WBA Position: Q3 2025 in Review

Geneos Wealth Management sold out of Walgreens Boots Alliance (WBA) in Q3 2025, closing a stake of 20,178 shares — an estimated $232K sold.

Geneos Wealth Management first reported a position in WBA in Q1 2016 and held it in 38 quarters. The position peaked at $2.14M in Q1 2019. 9 funds tracked by Wall St. Rank hold WBA as of Q3 2025.

Geneos Wealth Management reported no remaining Walgreens Boots Alliance position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 20,178 Walgreens Boots Alliance shares in Q3 2025, an estimated $232K.
Geneos Wealth Management first reported a position in Walgreens Boots Alliance in Q1 2016 and held it in 38 quarters.
Geneos Wealth Management's Walgreens Boots Alliance position peaked at $2.14M in Q1 2019.
9 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.